The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Sacral Neuromodulation System Market Research Report 2024
Synopsis
Sacral neuromodulation, also known as sacral nerve stimulation, is a type of electrical stimulation. Sacral neuromodulation system is an implanted system that can help improve the functioning of the bladder by sending electrical signals to the nerves, which control bladder activities.
The global Sacral Neuromodulation System market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Sacral Neuromodulation System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Sacral Neuromodulation System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Sacral Neuromodulation System in Spinal Cord Stimulation is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Sacral Neuromodulation System include Medtronic, Inc. (US), Boston Scientific Corporation (US), St. Jude Medical, Inc. (US), Synapse Biomedical, Inc. (US), Nevro Corporation (US), Neurosigma, Inc. (US), Neuropace, Inc. (US), Neuronetics, Inc. (US) and Cyberonics, Inc. (US), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Sacral Neuromodulation System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sacral Neuromodulation System.
Report Scope
The Sacral Neuromodulation System market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sacral Neuromodulation System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sacral Neuromodulation System companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic, Inc. (US)
Boston Scientific Corporation (US)
St. Jude Medical, Inc. (US)
Synapse Biomedical, Inc. (US)
Nevro Corporation (US)
Neurosigma, Inc. (US)
Neuropace, Inc. (US)
Neuronetics, Inc. (US)
Cyberonics, Inc. (US)
BioControl Medical (Israel)
Segment by Type
Internal Neuromodulation System
External Neuromodulation System
Segment by Application
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagus Nerve Stimulation
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sacral Neuromodulation System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Sacral neuromodulation, also known as sacral nerve stimulation, is a type of electrical stimulation. Sacral neuromodulation system is an implanted system that can help improve the functioning of the bladder by sending electrical signals to the nerves, which control bladder activities.
The global Sacral Neuromodulation System market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Sacral Neuromodulation System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Sacral Neuromodulation System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Sacral Neuromodulation System in Spinal Cord Stimulation is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Sacral Neuromodulation System include Medtronic, Inc. (US), Boston Scientific Corporation (US), St. Jude Medical, Inc. (US), Synapse Biomedical, Inc. (US), Nevro Corporation (US), Neurosigma, Inc. (US), Neuropace, Inc. (US), Neuronetics, Inc. (US) and Cyberonics, Inc. (US), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Sacral Neuromodulation System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sacral Neuromodulation System.
Report Scope
The Sacral Neuromodulation System market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sacral Neuromodulation System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sacral Neuromodulation System companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic, Inc. (US)
Boston Scientific Corporation (US)
St. Jude Medical, Inc. (US)
Synapse Biomedical, Inc. (US)
Nevro Corporation (US)
Neurosigma, Inc. (US)
Neuropace, Inc. (US)
Neuronetics, Inc. (US)
Cyberonics, Inc. (US)
BioControl Medical (Israel)
Segment by Type
Internal Neuromodulation System
External Neuromodulation System
Segment by Application
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagus Nerve Stimulation
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sacral Neuromodulation System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sacral Neuromodulation System Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Internal Neuromodulation System
1.2.3 External Neuromodulation System
1.3 Market by Application
1.3.1 Global Sacral Neuromodulation System Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Spinal Cord Stimulation
1.3.3 Deep Brain Stimulation
1.3.4 Sacral Nerve Stimulation
1.3.5 Vagus Nerve Stimulation
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sacral Neuromodulation System Market Perspective (2019-2030)
2.2 Sacral Neuromodulation System Growth Trends by Region
2.2.1 Global Sacral Neuromodulation System Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Sacral Neuromodulation System Historic Market Size by Region (2019-2024)
2.2.3 Sacral Neuromodulation System Forecasted Market Size by Region (2025-2030)
2.3 Sacral Neuromodulation System Market Dynamics
2.3.1 Sacral Neuromodulation System Industry Trends
2.3.2 Sacral Neuromodulation System Market Drivers
2.3.3 Sacral Neuromodulation System Market Challenges
2.3.4 Sacral Neuromodulation System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sacral Neuromodulation System Players by Revenue
3.1.1 Global Top Sacral Neuromodulation System Players by Revenue (2019-2024)
3.1.2 Global Sacral Neuromodulation System Revenue Market Share by Players (2019-2024)
3.2 Global Sacral Neuromodulation System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sacral Neuromodulation System Revenue
3.4 Global Sacral Neuromodulation System Market Concentration Ratio
3.4.1 Global Sacral Neuromodulation System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sacral Neuromodulation System Revenue in 2023
3.5 Sacral Neuromodulation System Key Players Head office and Area Served
3.6 Key Players Sacral Neuromodulation System Product Solution and Service
3.7 Date of Enter into Sacral Neuromodulation System Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sacral Neuromodulation System Breakdown Data by Type
4.1 Global Sacral Neuromodulation System Historic Market Size by Type (2019-2024)
4.2 Global Sacral Neuromodulation System Forecasted Market Size by Type (2025-2030)
5 Sacral Neuromodulation System Breakdown Data by Application
5.1 Global Sacral Neuromodulation System Historic Market Size by Application (2019-2024)
5.2 Global Sacral Neuromodulation System Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Sacral Neuromodulation System Market Size (2019-2030)
6.2 North America Sacral Neuromodulation System Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Sacral Neuromodulation System Market Size by Country (2019-2024)
6.4 North America Sacral Neuromodulation System Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sacral Neuromodulation System Market Size (2019-2030)
7.2 Europe Sacral Neuromodulation System Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Sacral Neuromodulation System Market Size by Country (2019-2024)
7.4 Europe Sacral Neuromodulation System Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sacral Neuromodulation System Market Size (2019-2030)
8.2 Asia-Pacific Sacral Neuromodulation System Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Sacral Neuromodulation System Market Size by Region (2019-2024)
8.4 Asia-Pacific Sacral Neuromodulation System Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sacral Neuromodulation System Market Size (2019-2030)
9.2 Latin America Sacral Neuromodulation System Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Sacral Neuromodulation System Market Size by Country (2019-2024)
9.4 Latin America Sacral Neuromodulation System Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sacral Neuromodulation System Market Size (2019-2030)
10.2 Middle East & Africa Sacral Neuromodulation System Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Sacral Neuromodulation System Market Size by Country (2019-2024)
10.4 Middle East & Africa Sacral Neuromodulation System Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic, Inc. (US)
11.1.1 Medtronic, Inc. (US) Company Detail
11.1.2 Medtronic, Inc. (US) Business Overview
11.1.3 Medtronic, Inc. (US) Sacral Neuromodulation System Introduction
11.1.4 Medtronic, Inc. (US) Revenue in Sacral Neuromodulation System Business (2019-2024)
11.1.5 Medtronic, Inc. (US) Recent Development
11.2 Boston Scientific Corporation (US)
11.2.1 Boston Scientific Corporation (US) Company Detail
11.2.2 Boston Scientific Corporation (US) Business Overview
11.2.3 Boston Scientific Corporation (US) Sacral Neuromodulation System Introduction
11.2.4 Boston Scientific Corporation (US) Revenue in Sacral Neuromodulation System Business (2019-2024)
11.2.5 Boston Scientific Corporation (US) Recent Development
11.3 St. Jude Medical, Inc. (US)
11.3.1 St. Jude Medical, Inc. (US) Company Detail
11.3.2 St. Jude Medical, Inc. (US) Business Overview
11.3.3 St. Jude Medical, Inc. (US) Sacral Neuromodulation System Introduction
11.3.4 St. Jude Medical, Inc. (US) Revenue in Sacral Neuromodulation System Business (2019-2024)
11.3.5 St. Jude Medical, Inc. (US) Recent Development
11.4 Synapse Biomedical, Inc. (US)
11.4.1 Synapse Biomedical, Inc. (US) Company Detail
11.4.2 Synapse Biomedical, Inc. (US) Business Overview
11.4.3 Synapse Biomedical, Inc. (US) Sacral Neuromodulation System Introduction
11.4.4 Synapse Biomedical, Inc. (US) Revenue in Sacral Neuromodulation System Business (2019-2024)
11.4.5 Synapse Biomedical, Inc. (US) Recent Development
11.5 Nevro Corporation (US)
11.5.1 Nevro Corporation (US) Company Detail
11.5.2 Nevro Corporation (US) Business Overview
11.5.3 Nevro Corporation (US) Sacral Neuromodulation System Introduction
11.5.4 Nevro Corporation (US) Revenue in Sacral Neuromodulation System Business (2019-2024)
11.5.5 Nevro Corporation (US) Recent Development
11.6 Neurosigma, Inc. (US)
11.6.1 Neurosigma, Inc. (US) Company Detail
11.6.2 Neurosigma, Inc. (US) Business Overview
11.6.3 Neurosigma, Inc. (US) Sacral Neuromodulation System Introduction
11.6.4 Neurosigma, Inc. (US) Revenue in Sacral Neuromodulation System Business (2019-2024)
11.6.5 Neurosigma, Inc. (US) Recent Development
11.7 Neuropace, Inc. (US)
11.7.1 Neuropace, Inc. (US) Company Detail
11.7.2 Neuropace, Inc. (US) Business Overview
11.7.3 Neuropace, Inc. (US) Sacral Neuromodulation System Introduction
11.7.4 Neuropace, Inc. (US) Revenue in Sacral Neuromodulation System Business (2019-2024)
11.7.5 Neuropace, Inc. (US) Recent Development
11.8 Neuronetics, Inc. (US)
11.8.1 Neuronetics, Inc. (US) Company Detail
11.8.2 Neuronetics, Inc. (US) Business Overview
11.8.3 Neuronetics, Inc. (US) Sacral Neuromodulation System Introduction
11.8.4 Neuronetics, Inc. (US) Revenue in Sacral Neuromodulation System Business (2019-2024)
11.8.5 Neuronetics, Inc. (US) Recent Development
11.9 Cyberonics, Inc. (US)
11.9.1 Cyberonics, Inc. (US) Company Detail
11.9.2 Cyberonics, Inc. (US) Business Overview
11.9.3 Cyberonics, Inc. (US) Sacral Neuromodulation System Introduction
11.9.4 Cyberonics, Inc. (US) Revenue in Sacral Neuromodulation System Business (2019-2024)
11.9.5 Cyberonics, Inc. (US) Recent Development
11.10 BioControl Medical (Israel)
11.10.1 BioControl Medical (Israel) Company Detail
11.10.2 BioControl Medical (Israel) Business Overview
11.10.3 BioControl Medical (Israel) Sacral Neuromodulation System Introduction
11.10.4 BioControl Medical (Israel) Revenue in Sacral Neuromodulation System Business (2019-2024)
11.10.5 BioControl Medical (Israel) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Sacral Neuromodulation System Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Internal Neuromodulation System
Table 3. Key Players of External Neuromodulation System
Table 4. Global Sacral Neuromodulation System Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Sacral Neuromodulation System Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Sacral Neuromodulation System Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Sacral Neuromodulation System Market Share by Region (2019-2024)
Table 8. Global Sacral Neuromodulation System Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Sacral Neuromodulation System Market Share by Region (2025-2030)
Table 10. Sacral Neuromodulation System Market Trends
Table 11. Sacral Neuromodulation System Market Drivers
Table 12. Sacral Neuromodulation System Market Challenges
Table 13. Sacral Neuromodulation System Market Restraints
Table 14. Global Sacral Neuromodulation System Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Sacral Neuromodulation System Market Share by Players (2019-2024)
Table 16. Global Top Sacral Neuromodulation System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sacral Neuromodulation System as of 2023)
Table 17. Ranking of Global Top Sacral Neuromodulation System Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Sacral Neuromodulation System Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Sacral Neuromodulation System Product Solution and Service
Table 21. Date of Enter into Sacral Neuromodulation System Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Sacral Neuromodulation System Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Sacral Neuromodulation System Revenue Market Share by Type (2019-2024)
Table 25. Global Sacral Neuromodulation System Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Sacral Neuromodulation System Revenue Market Share by Type (2025-2030)
Table 27. Global Sacral Neuromodulation System Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Sacral Neuromodulation System Revenue Market Share by Application (2019-2024)
Table 29. Global Sacral Neuromodulation System Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Sacral Neuromodulation System Revenue Market Share by Application (2025-2030)
Table 31. North America Sacral Neuromodulation System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Sacral Neuromodulation System Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Sacral Neuromodulation System Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Sacral Neuromodulation System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Sacral Neuromodulation System Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Sacral Neuromodulation System Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Sacral Neuromodulation System Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Sacral Neuromodulation System Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Sacral Neuromodulation System Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Sacral Neuromodulation System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Sacral Neuromodulation System Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Sacral Neuromodulation System Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Sacral Neuromodulation System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Sacral Neuromodulation System Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Sacral Neuromodulation System Market Size by Country (2025-2030) & (US$ Million)
Table 46. Medtronic, Inc. (US) Company Detail
Table 47. Medtronic, Inc. (US) Business Overview
Table 48. Medtronic, Inc. (US) Sacral Neuromodulation System Product
Table 49. Medtronic, Inc. (US) Revenue in Sacral Neuromodulation System Business (2019-2024) & (US$ Million)
Table 50. Medtronic, Inc. (US) Recent Development
Table 51. Boston Scientific Corporation (US) Company Detail
Table 52. Boston Scientific Corporation (US) Business Overview
Table 53. Boston Scientific Corporation (US) Sacral Neuromodulation System Product
Table 54. Boston Scientific Corporation (US) Revenue in Sacral Neuromodulation System Business (2019-2024) & (US$ Million)
Table 55. Boston Scientific Corporation (US) Recent Development
Table 56. St. Jude Medical, Inc. (US) Company Detail
Table 57. St. Jude Medical, Inc. (US) Business Overview
Table 58. St. Jude Medical, Inc. (US) Sacral Neuromodulation System Product
Table 59. St. Jude Medical, Inc. (US) Revenue in Sacral Neuromodulation System Business (2019-2024) & (US$ Million)
Table 60. St. Jude Medical, Inc. (US) Recent Development
Table 61. Synapse Biomedical, Inc. (US) Company Detail
Table 62. Synapse Biomedical, Inc. (US) Business Overview
Table 63. Synapse Biomedical, Inc. (US) Sacral Neuromodulation System Product
Table 64. Synapse Biomedical, Inc. (US) Revenue in Sacral Neuromodulation System Business (2019-2024) & (US$ Million)
Table 65. Synapse Biomedical, Inc. (US) Recent Development
Table 66. Nevro Corporation (US) Company Detail
Table 67. Nevro Corporation (US) Business Overview
Table 68. Nevro Corporation (US) Sacral Neuromodulation System Product
Table 69. Nevro Corporation (US) Revenue in Sacral Neuromodulation System Business (2019-2024) & (US$ Million)
Table 70. Nevro Corporation (US) Recent Development
Table 71. Neurosigma, Inc. (US) Company Detail
Table 72. Neurosigma, Inc. (US) Business Overview
Table 73. Neurosigma, Inc. (US) Sacral Neuromodulation System Product
Table 74. Neurosigma, Inc. (US) Revenue in Sacral Neuromodulation System Business (2019-2024) & (US$ Million)
Table 75. Neurosigma, Inc. (US) Recent Development
Table 76. Neuropace, Inc. (US) Company Detail
Table 77. Neuropace, Inc. (US) Business Overview
Table 78. Neuropace, Inc. (US) Sacral Neuromodulation System Product
Table 79. Neuropace, Inc. (US) Revenue in Sacral Neuromodulation System Business (2019-2024) & (US$ Million)
Table 80. Neuropace, Inc. (US) Recent Development
Table 81. Neuronetics, Inc. (US) Company Detail
Table 82. Neuronetics, Inc. (US) Business Overview
Table 83. Neuronetics, Inc. (US) Sacral Neuromodulation System Product
Table 84. Neuronetics, Inc. (US) Revenue in Sacral Neuromodulation System Business (2019-2024) & (US$ Million)
Table 85. Neuronetics, Inc. (US) Recent Development
Table 86. Cyberonics, Inc. (US) Company Detail
Table 87. Cyberonics, Inc. (US) Business Overview
Table 88. Cyberonics, Inc. (US) Sacral Neuromodulation System Product
Table 89. Cyberonics, Inc. (US) Revenue in Sacral Neuromodulation System Business (2019-2024) & (US$ Million)
Table 90. Cyberonics, Inc. (US) Recent Development
Table 91. BioControl Medical (Israel) Company Detail
Table 92. BioControl Medical (Israel) Business Overview
Table 93. BioControl Medical (Israel) Sacral Neuromodulation System Product
Table 94. BioControl Medical (Israel) Revenue in Sacral Neuromodulation System Business (2019-2024) & (US$ Million)
Table 95. BioControl Medical (Israel) Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sacral Neuromodulation System Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Sacral Neuromodulation System Market Share by Type: 2023 VS 2030
Figure 3. Internal Neuromodulation System Features
Figure 4. External Neuromodulation System Features
Figure 5. Global Sacral Neuromodulation System Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Sacral Neuromodulation System Market Share by Application: 2023 VS 2030
Figure 7. Spinal Cord Stimulation Case Studies
Figure 8. Deep Brain Stimulation Case Studies
Figure 9. Sacral Nerve Stimulation Case Studies
Figure 10. Vagus Nerve Stimulation Case Studies
Figure 11. Sacral Neuromodulation System Report Years Considered
Figure 12. Global Sacral Neuromodulation System Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Sacral Neuromodulation System Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Sacral Neuromodulation System Market Share by Region: 2023 VS 2030
Figure 15. Global Sacral Neuromodulation System Market Share by Players in 2023
Figure 16. Global Top Sacral Neuromodulation System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sacral Neuromodulation System as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Sacral Neuromodulation System Revenue in 2023
Figure 18. North America Sacral Neuromodulation System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Sacral Neuromodulation System Market Share by Country (2019-2030)
Figure 20. United States Sacral Neuromodulation System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Sacral Neuromodulation System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Sacral Neuromodulation System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Sacral Neuromodulation System Market Share by Country (2019-2030)
Figure 24. Germany Sacral Neuromodulation System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Sacral Neuromodulation System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Sacral Neuromodulation System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Sacral Neuromodulation System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Sacral Neuromodulation System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Sacral Neuromodulation System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Sacral Neuromodulation System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Sacral Neuromodulation System Market Share by Region (2019-2030)
Figure 32. China Sacral Neuromodulation System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Sacral Neuromodulation System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Sacral Neuromodulation System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Sacral Neuromodulation System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Sacral Neuromodulation System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Sacral Neuromodulation System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Sacral Neuromodulation System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Sacral Neuromodulation System Market Share by Country (2019-2030)
Figure 40. Mexico Sacral Neuromodulation System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Sacral Neuromodulation System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Sacral Neuromodulation System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Sacral Neuromodulation System Market Share by Country (2019-2030)
Figure 44. Turkey Sacral Neuromodulation System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Sacral Neuromodulation System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Medtronic, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2019-2024)
Figure 47. Boston Scientific Corporation (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2019-2024)
Figure 48. St. Jude Medical, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2019-2024)
Figure 49. Synapse Biomedical, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2019-2024)
Figure 50. Nevro Corporation (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2019-2024)
Figure 51. Neurosigma, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2019-2024)
Figure 52. Neuropace, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2019-2024)
Figure 53. Neuronetics, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2019-2024)
Figure 54. Cyberonics, Inc. (US) Revenue Growth Rate in Sacral Neuromodulation System Business (2019-2024)
Figure 55. BioControl Medical (Israel) Revenue Growth Rate in Sacral Neuromodulation System Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
